Patents by Inventor John F. Batchelor

John F. Batchelor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5403934
    Abstract: A compound of formula (I): ##STR1## wherein R.sup.1 represents a hydrogen or halogen atom, or a cyano group;R.sup.2 represents an optionally substituted carbocyclic group having 6 to 10 ring atoms and containing at least one aromatic ring; an optionally substituted heterocyclic group having 5 to 10 ring atoms, including 1 to 4 heteroatoms selected from O, N and S, and containing at least one aromatic ring; or an optionally substituted C.sub.3-6 cycloalkyl, C.sub.3-6 cycloalkyl- C.sub.1-6 alkyl, or C.sub.1-10 alkyl group;R.sup.3 and R.sup.4, which may be the same or different, each represent a hydrogen or halogen atom, or a C.sub.1-6 alkyl group optionally substituted by 1 to 3 halogen atoms; andR.sup.5 represents a hydrogen atom, a hydroxyl group, or a C.sub.1-6 alkyl group, optionally substituted by hydroxy, carboxy, amino or mono- or di-(C.sub.1-4)alkyl amino,and salts and other physiologically functional derivative thereof.The compounds are useful in the treatment of parasitic infections eg.
    Type: Grant
    Filed: July 15, 1994
    Date of Patent: April 4, 1995
    Assignee: Burroughs Wellcome Co.
    Inventors: John F. Batchelor, Clive L. Yeates
  • Patent number: 4902701
    Abstract: Tricyclic compounds of formula (I) ##STR1## wherein X.sup.1 is a carboxyl or 5-tetrazolyl groupX.sup.2 is carbonyl or methyleneX.sup.3 is hydroxyl or a group --X.sup.4 (C.sub.n H.sub.2n)X.sup.5whereX.sup.4 is oxygen or sulphurX.sup.5 is hydrogen or a group --OX.sup.6whereX.sup.6 is hydrogen, alkanoyl of 1 to 4 carbon atoms or a group --(C.sub.m H.sub.2m)X.sup.7whereX.sup.7 is hydrogen or a group --OX.sup.8whereX.sup.8 is hydrogen or alkanoyl of 1 to 4 carbon atoms and m and n are each, independently, an integer from 1 to 4, together with salts thereof,provided that when X.sup.5 is a group --OX.sup.6 then n is always greater than 1 and X.sup.4 and X.sup.5 are attached to different carbon atomsand that when X.sup.7 is a group --OX.sup.8 then m is always greater than 1 and no single carbon atom in the radical --(C.sub.m H.sub.2m)-- is attached to two oxygen atoms.
    Type: Grant
    Filed: September 3, 1986
    Date of Patent: February 20, 1990
    Assignee: Burroughs Welcome Co.
    Inventors: John F. Batchelor, Richard M. Hyde, Williasm R. King, David J. Livingstone
  • Patent number: 4801593
    Abstract: A method of treating or preventing viral infections, in particular rhinovirus infections comprising the administration of an effective amount of a 2-phenyltetralin derivative or a heterocyclic analogue thereof. Pharmaceutical compositions containing these compounds, and some novel compounds are also disclosed.
    Type: Grant
    Filed: August 11, 1980
    Date of Patent: January 31, 1989
    Assignee: Burroughs Wellcome Co.
    Inventors: Harold F. Hodson, John F. Batchelor, John W. T. Selway, Jeremy G. Vinter, Ramachanderan Iyer
  • Patent number: 4791136
    Abstract: Use of compounds of formula (I) ##STR1## to provide a more effective delivery of oxygen to the tissues of a mammalian, including human, recipient.In vivo applications include the relief or amelioration of conditions wherein there is tissue hypoxia; in vitro the compounds are of use in the storage of mammalian, including human, red blood cells to maintain their oxygen-delivery capacity and prolong their useful storage life.Also provided is a sterile, sealed vessel containing an anticoagulant, a non-toxic amount of a compound of formula (I) and optionally mammalian, in particular human, red blood cells.
    Type: Grant
    Filed: July 30, 1986
    Date of Patent: December 13, 1988
    Assignee: Burroughs Wellcome Co.
    Inventors: John F. Batchelor, Richard M. Hyde, David J. Livingstone
  • Patent number: 4626431
    Abstract: Use of compounds of formula (I) ##STR1## to provide a more effective delivery of oxygen to the tissues of a mammalian, including human, recipient.In vivo applications include the relief or amelioration of conditions wherein there is tissue hypoxia; in vitro the compounds are of use in the storage of mammalian, including human, red blood cells to maintain their oxygen-delivery capacity and prolong their useful storage life.Also provided is a sterile, sealed vessel containing an anticoagulant, a non-toxic amount of a compound of formula (I) and optionally mammalian, in particular human, red blood cells.
    Type: Grant
    Filed: October 19, 1984
    Date of Patent: December 2, 1986
    Assignee: Burroughs Wellcome Co.
    Inventors: John F. Batchelor, Richard M. Hyde, David J. Livingstone
  • Patent number: 4563468
    Abstract: 2-Pyridyl chroman and derivatives thereof have been discovered to have potent anti-viral activities, i.e. particular against rhinovirus. Novel compounds and their pharmaceutically acceptable salts, pharmaceutical formulations containing the compounds of this invention and the treatment of viral infections with these formulations are all disclosed. 2-(3-Pyridyl)chroman and 6-chloro-2-(3-pyridyl)chroman are examples of especially active compounds of this invention.
    Type: Grant
    Filed: August 11, 1980
    Date of Patent: January 7, 1986
    Assignee: Burroughs Wellcome Co.
    Inventors: John F. Batchelor, Harold F. Hodson, John W. T. Selway
  • Patent number: 4461907
    Abstract: Novel compounds of formula (IID) ##STR1## wherein either both X and Y represent groups independently selected from amino and lower alkylamino, or one of X and Y represents a group selected from amino and lower alkylamino and the other of X and Y represents a hydrogen atom have been found to be active against rhinoviruses and other viruses. Processes for producing these compounds include reduction of flavanone derivatives or of flavenes. Alternatively, reductive cyclization of chalcones affords the compounds. These may also be prepared by condensation of o-(substituted methyl)phenols with styrene derivatives.Pharmaceutical formulations and methods for the administration of the compounds are described.
    Type: Grant
    Filed: July 14, 1982
    Date of Patent: July 24, 1984
    Inventors: John F. Batchelor, Denis J. Bauer, Harold F. Hodson, John W. T. Selway, David A. B. Young
  • Patent number: 4452991
    Abstract: A method of treating or preventing viral infections, in particular rhinovirus infections comprising the administration of an effective amount of a flavan derivative of formula (I). ##STR1## Pharmaceutical compositions containing these compounds, and some novel compounds are also disclosed.
    Type: Grant
    Filed: April 9, 1981
    Date of Patent: June 5, 1984
    Inventors: John F. Batchelor, Jeremy G. Vinter, Harold F. Hodson
  • Patent number: 4177257
    Abstract: Certain tricyclic sulphone compounds each of which is substituted in the 1-,2-,3- or 4-position by a carboxyl or (5-tetrazolyl) group and each of which is optionally substituted in the 5-,6-,7- or 8-position by a second carboxyl or (5-tetrazolyl) group or a substituent selected from cyano, halogen, nitro, alkyl, alkoxy, acyl, amino, acylamino, thioalkyl, alkylsulphinyl and alkylsulphonyl, as well as salts, and optionally substituted esters and amides of the carboxyl substituted compounds and alkyl derivatives of the tetrazolyl substituted compounds, are useful for the relief or prophylaxis of allergic conditions.
    Type: Grant
    Filed: March 11, 1977
    Date of Patent: December 4, 1979
    Assignee: Burroughs Wellcome Co.
    Inventors: Harold F. Hodson, John F. Batchelor
  • Patent number: 4145350
    Abstract: Certain tricyclic sulphone compounds each of which is substituted in the 1-, 2-, 3- or 4-position by a carboxyl or (5-tetrazolyl) group and each of which is optionally substituted in the 5-, 6-, 7- or 8-position by a second carboxyl or (5-tetrazolyl) group or a substituent selected from cyano, halogen, nitro, alkyl, alkoxy, acyl, amino, acylamino, thioalkyl, alkylsulphinyl and alkylsulphonyl, as well as salts, and optionally substituted esters and amides of the carboxyl substituted compounds and alkyl derivatives of the tetrazolyl substituted compounds, are useful for the relief or prophylaxis of allergic conditions.
    Type: Grant
    Filed: February 22, 1977
    Date of Patent: March 20, 1979
    Assignee: Burroughs Wellcome Co.
    Inventors: Harold F. Hodson, John F. Batchelor